Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CYAD-101
i
Other names:
CYAD-101, non-gene edited allogeneic CAR-T, TIM8-CYAD-01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Celyad Oncology
Drug class:
NKG2DL-targeted CAR-T immunotherapy
Related drugs:
‹
CTM-N2D (0)
CYAD-02 (0)
NKG2D CAR-NK cell therapy (0)
CTM-N2D (0)
CYAD-02 (0)
NKG2D CAR-NK cell therapy (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
CYAD-101
Sensitive: C3 – Early Trials
CYAD-101
Sensitive
:
C3
CYAD-101
Sensitive: C3 – Early Trials
CYAD-101
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login